Susquehanna International »

Candel Therapeutics shares owned by Susquehanna International

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Susquehanna International

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.5M 224k 6.93
2024-06-30 $399k 64k 6.20